|
|
|
|
|
Session 104
Poster Abstracts Adherence, Quality of Life, and Factors Related to Treatment Friday, 1:30 - 3:30 pm Hall A |
Background: Active drug
use is associated with poor antiretroviral adherence, but correlates of
adherence in injection drug users have not been determined. Further, the
prevalence of ART medication errors among injection drug users is unknown.
Methods: We report
baseline data from INSPIRE, a 4-city randomized trial of a behavioral
intervention to reduce sex and injection risks and improve health care
utilization and adherence among HIV-infected injection drug users. We used
ACASI to assess adherence, asking subjects their precise ART prescriptions and
how many pills they skipped the preceding day. Good adherence was defined as
mean overall adherence of ≥ 95%. Medication errors were defined as
incorrect daily doses of 1 or more ART, using both standard and alternative ART
prescriptions as the reference.
Results: Of 1161
HIV-infected Injection drug users, 55% (n = 636) were taking ART and 48% (n = 560)
were taking HAART. Among those taking ART, 26% had a viral load < 400
copies/mL. Most subjects (74%, n = 473) had good
adherence, which was strongly associated with having an undetectable viral load
(p < 0.001). Good adherence was
also associated with being a high school graduate (OR 95% CI 1.7 [1.2 to 2.5]),
male sex (1.4 [1.0 to 2.0]), not being homeless (2.0 [1.4 to 3.0]), no cocaine
use in the past 3 months ([1.9 [1.2 to 3.0]), and not sharing injection
equipment (2.4 [1.6 to 3.5]). Several psychosocial factors were associated (p ≤ 0.01) with good adherence: greater perceived social support, greater
self-efficacy for disclosing drug use to providers and for taking HIV medications,
positive attitudes toward HIV medication, better communication with providers,
and not being depressed. Medication errors were made by 54% (n = 346), and were
associated (p < 0.001) with
detectable viremia and fewer CD4 cells. In
multivariate analyses, the strongest predictors of good adherence were
self-efficacy for taking HIV medications (ORadj
95% CI 2.1 [1.5 to 2.9]), and positive attitudes toward HIV medications (1.8
[1.0 to 3.4]), and the strongest predictors of poor adherence were sharing
injection equipment (2.2 [1.4 to 3.6]), and depression (1.3 [1.0 to 1.7]). The
strongest independent predictors of medication errors were worse self-perceived
health status (ORadj 95% CI 1.5 [1.1 to
2.1]), poorer self-efficacy for safer drug use (1.2 [1.0 to 1.4]), and worse
attitudes toward HIV medications (1.9 [1.2 to 3.1]).
Conclusions: Adherence
interventions for injection drug users should focus on reducing medication
errors, improving self-efficacy and attitudes toward HIV medications, and
treating depression.
Keywords: adherence
![]() |